Abstract
Aim
To compare the clinical, obstetric and neonatal parameters between patients with > 34-week gestation having severe preeclampsia receiving magnesium sulphate and those with > 34-week gestation with preeclampsia but not receiving magnesium sulphate.
Materials and Methods
Single-centre prospective study studied 60 patients in each of the two groups. Magnesium sulphate was administered by Pritchard regimen as per standard protocol. Standard obstetric management was followed for both groups. In the severe preeclampsia/eclampsia group, maternal blood sample was analysed for serum magnesium levels. The duration of exposure, the amount of magnesium sulphate received and time elapsed between last dose of magnesium sulphate and delivery were all noted. Neonatal assessment was done. The various parameters including age, parity, blood pressure, mode of termination of pregnancy, NICU admission rate, incidence of hypotonia in the newborn and other neonatal parameters were tabulated and compared.
Results
The two groups were comparable with respect to age and parity. Need for induction of labour was higher in the group with severe preeclampsia/eclampsia. Rate of LSCS and birth weights were comparable between the two groups. NICU admission rate and incidence of hypotonia were higher in those who received magnesium sulphate. Amount of magnesium sulphate received and total duration of magnesium sulphate did not correlate with NICU admission rates.
Conclusions
Neonatal morbidity, in terms of higher NICU admission rates and hypotonia, is higher in patients receiving magnesium sulphate.
Similar content being viewed by others
References
Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. BioMed Central 2013;13:195. http://www.ncbi.nlm.nih.gov/pubmed/24139447.
Bain E, Bubner T, Ashwood P et al. Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand. Aust N Z J Obstet Gynaecol. 2013;53(1):86–9.
Nguyen TMN, Crowther CA, Wilkinson D et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD009395.pub2.
Drinkwater J. Magnesium sulphate for pre-eclampsia: care of the neonate. Pract Midwife. 2011;14(11):17–9.
Greenberg MB, Penn AA, Thomas LJ et al. Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate. Am J Obstet Gynecol. 2011; 204(6):515.e1–515.e7. http://www.ncbi.nlm.nih.gov/pubmed/21376302.
Greenberg MB, Penn AA, Whitaker KR et al. Effect of magnesium sulfate exposure on term neonates. J Perinatol. 2013;33(3):188–93.
Girsen AI, Greenberg MB, El-Sayed YY et al. Magnesium sulfate exposure and neonatal intensive care unit admission at term. J Perinatol. 2015;35(3):181–5.
Das M, Chaudhuri P, Mondal B et al. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J Pharmacol. 2015;47(5):502.
Abbassi-Ghanavati M, Alexander J, McIntire D et al. Neonatal effects of magnesium sulfate given to the mother. Am J Perinatol. 2012;29(10):795–800.
Havranek T, Ashmeade TL, Afanador M et al. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates. Neonatology. 2011;100(1):44–9.
Sherwin CMT, Balch A, Campbell SC et al. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic Clin Pharmacol Toxicol. 2014;114(4):318–22.
Drassinower D, Friedman AM, Levin H et al. Does magnesium exposure affect neonatal resuscitation? Am J Obstet Gynecol. 2015; 213(3):424.e1–424.e5. http://www.ncbi.nlm.nih.gov/pubmed/26026919.
Yokoyama K, Takahashi N, Yada Y et al. Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev. 2010;86(3):187–91.
Duffy CR, Odibo AO, Roehl KA et al. Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor. Obstet Gynecol. 2012;119(6):1129–36.
Chaudhuri S, Bhattacharyya N, Biswas PK et al. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia. J Obstet Gynaecol Res. 2009;35(1):119–25.
Tudela CM, McIntire DD, Alexander JM. Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis. Obstet Gynecol. 2013;121(2):314–20.
Brookfield KF, Su F, Elkomy MH et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016; 214(6):737.e1–737.e9. http://www.ncbi.nlm.nih.gov/pubmed/26767791.
Long Q, Oladapo O, Leathersich S et al. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey. BJOG. 2016. http://www.ncbi.nlm.nih.gov/pubmed/27885772.
Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res. 2015;41(6):831–42.
Acknowledgments
The authors sincerely acknowledge the contribution of Late Dr Jayant S Rege towards this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical Approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Since it was a retrospective review of records, no informed consent was obtained from any patients for being included in the study. This article does not contain any studies with animal subjects.
Additional information
Arun Ambadkar, Registrar, in the Department of Obstetrics and Gynecology, Seth GS Medical College and KEM Hospital, Mumbai, India; Madhva Prasad MBBS, MS is working in the Department of Obstetrics and Gynecology, Seth GS Medical College and KEM Hospital, Mumbai, India; Anahita R Chauhan, MD, in the Department of Obstetrics and Gynecology, Seth GS Medical college and KEM Hospital, Mumbai, India.
Rights and permissions
About this article
Cite this article
Ambadkar, A., Prasad, M. & Chauhan, A.R. Neonatal Effects of Maternal Magnesium Sulphate in Late Preterm and Term Pregnancies. J Obstet Gynecol India 69, 25–30 (2019). https://doi.org/10.1007/s13224-017-1074-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-017-1074-4